Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Acutaas Chemicals Limited exports its products. Acutaas Chemicals Limited was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. The company was founded in 2004 and is based in Surat, India.
Metrics to compare | ACUA | Peers Peers - average of corresponding metrics from companies closely matching ACUA: GRANULES, HIKAL, AETHER, 002581, MOREPENLAB | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipACUAPeersSector |
---|---|---|---|---|
P/E Ratio | 62.9x | 31.5x | −0.5x | |
PEG Ratio | 0.25 | 0.80 | 0.00 | |
Price/Book | 7.6x | 3.6x | 2.6x | |
Price / LTM Sales | 9.9x | 4.2x | 3.2x | |
Upside (Analyst Target) | 22.1% | 6.8% | 42.0% | |
Fair Value Upside | Unlock | −2.2% | 6.6% | Unlock |